Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 120

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 120
---
100 |     | $                                                                                                                  |   925 |
|                        |     | 06/07/23   |     |                                                                 |   180 |     |                                                                   | — |     |                                                                                            |   120 |     | $                     |   578.00 |     |                        | 06/07/33 |     |                                                         | — |     |                                                              | — |     |                                                                                                     |   — |     |                                                                                                                    |     — |
|                        |     | 06/24/24   |     |                                                                 | 1,040 |     |                                                                   | — |     |                                                                                            |   520 |     | $                     |    47.40 |     |                        | 06/24/34 |     |                                                         | — |     |                                                              | — |     |                                                                                                     |   — |     |                                                                                                                    |     — |
|                        |     | 12/20/24   |     |                                                                 |   514 |     |                                                                   | — |     |                                                                                            | 1,028 |     | $                     |    19.00 |     |                        | 12/20/34 |     |                                                         | — |     |                                                              | — |     |                                                                                                     |   — |     | $                                                                                                                  |     — |

Named executive officers held stock options to
purchase a total of 17,415 shares of common stock as of June 30, 2025, with an aggregate grant date fair value of approximately $5.6 million,
the last of which vests in 2027. Stock options granted prior to August 20, 2021, vested on the grant date; the stock options granted on
August 20, 2021 vested 20% on the grant date, with the remaining stock options vesting in five equal annual installments beginning on
the first grant date anniversary; the stock options granted on June 7, 2023, vested 25% on the grant date, with the remaining stock options
vesting in four equal annual installments beginning on the first grant date anniversary; and the stock options and stock awards in the
form RSUs granted to the CEO on June 21, 2022 and June 29, 2023 vests in three equal annual installments beginning on the first grant
date anniversary. The RSU awarded on November 23, 2022 vested 25% on the grant date with the remaining RSU vesting in three equal annual